Matej Mikulic
Research expert covering health, pharma & medtech
Amgen - Statistics & Facts
Biotechnology company Amgen was originally founded as AMGen in 1980, standing for Applied Molecular Genetics. The company is headquartered in Thousand Oaks, California, but has establishments in many other countries around the world. Today, Amgen is the world’s largest pure play medical biotechnology company, generating 28.2 billion U.S. dollars of revenue and employing over 26 thousand people worldwide.
The U.S. market is essential
Amgen is among the larger biotech and pharma companies by market capitalization worldwide. Biopharmaceuticals manufactured by Amgen are also among the leading biotech drugs worldwide. Enbrel, Prolia, and Otezla are the company’s flagship products, responsible for over one third of Amgen’s total revenue. Interestingly, Amgen generates over 70 percent of its revenues on the domestic U.S. market.Research and development
As is common in the biopharmaceutical industry, Amgen spends a significant proportion of its income on research and development. In 2023, Amgen spent 17 percent of its total revenues on R&D purposes. Almost 40 percent of 4.8 billion U.S. dollars of R&D spending was for late-stage clinical programs, while the rest was for discovery research, early pipeline, and marketed products.
